Aster Dm Healthcare Ltd. · NSE:ASTERDM
Aster Dm Healthcare — Q3 FY2025 Earnings Presentation
38 slides from Aster Dm Healthcare's earnings presentation, Jan 31, 2025
Slide 1: Cover letter to stock exchanges
January 31, 2025 The Secretary The Manager, Listing Department, Listing Department, BSE Limited, The National Stock Exchange of India Ltd 1st Floor, Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street, Mumbai 400001 Bandra Kurla Complex Scrip Code: 540975 Bandra (East), Mumbai 400051
Slide 2: Earnings Presentation
Earnings Presentation For the quarter ending December 31, 2024
Slide 3: Disclaimer
Disclaimer • This presentation has been prepared by Aster DM Healthcare Limited (the "Company"), content of which was compiled from sources believed to be reliable for informational purposes only and are based on information regarding the Company and the economic, regulatory, market and other condit
Slide 4: Update on Merger of Aster DM & Quality Care
Update on Merger of Aster DM & Quality Care Received shareholders’ approval with overwhelming majority for: Shareholders Preferential Allotment (as defined below) as a consideration for Initial Acquisition (as defined below) Approval Shift of registered office of the Company Application made to
Slide 5: 9M FY 2025 Performance Summary - Aster India
9M FY 2025 Performance Summary- Aster India 3 Revenue Operating EBITDA1 Op EBITDA Margin Adjusted PAT2 RoCE (Pre-Tax) Financial (Post-NCI) 9MFY25 : INR 3,138 cr 9MFY25 : INR 613 cr 9MFY25 : 19.5% 9MFY25 : INR 251 cr 9MFY25 : 19.5% 15% 35% 288 bps 65% 480 bps 9MFY24 : INR 2,721 cr 9MFY24 : INR 453 cr
Slide 6: Aster India Performance Summary – Q3 and 9M FY 2025
Aster India Performance Summary – Q3 and 9M FY 2025 ▪ Overall Operating EBITDA margin of 19.5% in 9M FY25 (16.6% in 9M FY24) ▪ ALOS has improved to 3.2 days in 9M FY25 from 3.4 days in 9M FY24 ▪ Payor mix improved with Insurance business at 30% (i.e. +300 bps YoY) in 9M FY25. ▪ Core hospital busines
Slide 7: Company Overview
Company Overview
Slide 8: Aster India at a Glance
Aster India at a Glance Our Presence/Strength1 15 cities and 192 5,128 5 states Hospitals capacity beds 13 254 203 Clinics Labs and PECs Pharmacies3 Operational metrics (9M FY25) Karnataka & Maharashtra 67% 3.2 days INR 44,200+ Karnataka Hospital: 4, Beds: 1192 Occupancy ALOS ARPOB Maharashtra Hospi
Slide 9: Our Vision and Core Values
Our Vision and Core Values Excellence Respect “Surpassing current benchmarks constantly by continually “Treating people with utmost dignity, valuing challenging its ability and skills their culture contributions and fostering a Our Promise to take the organisation to culture that allows each individ
Slide 10: Aster India Revenue and Profitability Snapshot – 9M FY25
9 Aster India Revenue and Profitability Snapshot – 9M FY25 Revenue from Operations1 Operating EBITDA and Margin1,2 EBITDA and Margin1 Adjusted PAT and Margin3 (Post Ind As) (Post NCI) 16.6% 19.5% 15.7% 18.2% 5.6% 8.0% 3,138 613 572 2,721 251 453 426 153 9MFY24 9MFY25 9MFY24 9MF25 9MFY24 9MFY25 9MFY2
Slide 11: Aster India Revenue and Profitability Snapshot – Q3 FY25
10 Aster India Revenue and Profitability Snapshot – Q3 FY25 Revenue from Operations1 Operating EBITDA and Margin1,2 EBITDA and Margin1 Adjusted PAT and Margin3 (Post Ind As) (Post NCI) 17.7% 19.3% 16.4% 18.0% 6.5% 7.7% 1,050 949 202 189 81 168 155 62 15.3% 17.7% Q3FY24 Q3FY25 Q3FY24 Q3FY25 Q3FY24 Q3
Slide 12: Aster India Hospital and other New Business Performance – 9M FY25
Aster India Hospital and other New Business Performance – 9M FY25 % of Revenue Revenue Operating EBITDA(5) Hospitals and Clinics INR 3,020 Cr INR 673 Cr 94% 17% 22.3% Core established business YoY Revenue Growth Margins 19 hospitals(1) 13 clinics 5,128 capacity beds Labs and Pharmacies INR 208 Cr IN
Slide 13: Core Business Performance- Hospitals and Clinics
Core Business Performance- Hospitals and Clinics
Slide 14: Aster India - Hospital Financial Trends
Aster India - Hospital Financial Trends Hospital Operating EBITDA 1 Hospital Revenue Hospital EBITDA and Margin and Margin (In INR Cr) (In INR Cr) 20% 22% 11% 13% 12% 17% 19% 20% Margin 3,519 688 3,020 2,851 673 538 2,589 2,343 504 407 1,631 1,647 1,307 212 201 143 9MFY24 9MFY25 FY19 FY20 FY21 FY22
Slide 15: Aster India – Hospital Operational Trends
Aster India – Hospital Operational Trends No. of Hospitals No. of capacity beds Total patient volumes (In Mn) 4,857 5,128 4,867 3.3 19 19 19 4,317 2.9 17 3,905 2.7 3,693 3,757 2.5 3,460 14 14 2.2 2.2 13 12 1.8 1.5 9MFY24 9MFY25 FY19 FY20 FY21 FY22 FY23 FY24 9MFY24 9MFY25 FY19 FY20 FY21 FY22 FY23 FY2
Slide 16: Aster India - Hospitals & Clinics Revenue Mix
Aster India - Hospitals & Clinics Revenue Mix Geographical Revenue Mix1 (9M FY25) Specialty-wise Revenue Mix (9M FY25) Andhra & Telangana 12% Multi Speciality, 18% Cardiac Sciences , 14% Kerala 53% OP Pharmacy, Neuro Sciences, 11% Karnataka & Anaestheolgy, 13% Maharashtra 35% Child and Adolscent Hea
Slide 17: Aster India - Maturity Wise Hospital Performance – 9M FY25
16 Aster India - Maturity Wise Hospital Performance – 9M FY25 Key Performance indicators Operational Revenue4 Operating Maturity Hospitals3 Beds5 Operating (INR in Crs.) ARPOBD Occupancy EBITDA4 ROCE (Census) EBITDA %4 (INR Crs.) Over 6 73% 70% ₹529 10 ₹2,156 2,623 ₹ 45,600 67% 24.5% 36% Years 3-6 2
Slide 18: Aster India Hospitals: Pipeline Projects
17 Aster India Hospitals: Pipeline Projects Further addition of ~1700 beds, bringing the total bed capacity to ~6,800 by FY27 454 6,830 350 100 300 264 159 75 FY27 : 904 beds 5,128 FY26 : 564 beds FY25 : 334 beds 9M Aster Whitefield Aster Ramesh Aster MIMS Aster W&C Aster Capital Aster CMI** Aster M
Slide 19: Growth Strategy
Our strategic priorities towards driving future growth and improvement in profitability Focus Areas Capital ✓ Investing prudently in both brownfield (expanding existing units) and greenfield Investment A projects across clusters and opportunistically exploring inorganic opportunities Operational ✓ F
Slide 20: Aster India Financial Summary - Profitability Statement
Aster India Financial Summary- Profitability Statement Particulars Q3 FY25 Q3 FY24 YoY % 9M FY25 9M FY24 YoY % Revenue from Operations 1,050 949 11% 3,138 2,721 15% Material Cost2 247 229 713 684 Doctors Cost 229 213 691 596 Employee Cost 194 177 577 505 Other Cost 178 162 544 484 Operating EBITDA 2
Slide 21: Cluster Performance
Cluster Performance
Slide 22: Kerala Cluster: Hospitals and Bed Capacity
Kerala Cluster: Hospitals and Bed Capacity Revenue Contribution1 53% Aster Medcity MIMS Calicut MIMS Kottakkal Kochi, Kerala Kozhikode, Kerala Kottakkal, Kerala 2014, Owned 2013, Owned 2013, Owned CB: 862 OB: 662 CB: 698 OB: 477 CB:359 OB:282 MIMS Kannur Aster PMF Aster Mother Hospital Kannur, Keral
Slide 23: Kerala Cluster - Performance
Kerala Cluster - Performance Revenue (In INR Crs) 1,609 1,489 2,007 1,691 1,318 Operational Metrics 9M FY25 9M FY24 YoY Growth 875 935 701 ARPOBD (INR) 41,600+ 37,500+ 11% 9MFY24 9MFY25 FY19 FY20 FY21 FY22 FY23 FY24 Operating EBITDA1 (In INR Crs) 382 Occupancy 74% 80% -569 bps 317 430 9MFY25 356 255
Slide 24: Karnataka & Maharashtra Cluster: Hospitals and Bed Capacity
Karnataka & Maharashtra Cluster : Hospitals and Bed Capacity Revenue Contribution1 35% Aster CMI Aster Whitefield Aster RV Bengaluru, Karnataka Bengaluru, Karnataka Bengaluru, Karnataka 2014, O&M 2021, Leased 2019, O&M CB: 509 OB:366 CB: 347 OB:234 CB: 236 OB:168 Aster Aadhar Aster G Madegowda Kolha
Slide 25: Karnataka & Maharashtra Cluster - Performance
Karnataka & Maharashtra Cluster - Performance Revenue (In INR Crs) 1,054 1100 793 817 Operational Metrics 9M FY25 9M FY24 YoY Growth 655 442 433 310 ARPOBD (INR) 60,000+ 52,300+ 15% 9MFY24 9MFY25 FY19 FY20 FY21 FY22 FY23 FY24 Operating EBITDA1 Occupancy 64% 61% 241 bps 9M FY25 (In INR Crs) 244 217 1
Slide 26: Andhra & Telangana Cluster: Hospitals and Bed Capacity
Andhra & Telangana Cluster : Hospitals and Bed Capacity Revenue Contribution1 12% Ramesh Guntur Prime Hospitals – Ameerpet Ramesh Sanghamitra Guntur, AP Hyderabad, Telangana Ongole, AP 2016, Leased 2014, Leased 2018, Owned CB:350 OB:225 CB:158 OB:98 CB:150 OB:130 Aster Narayanadri Ramesh Main Centre
Slide 27: Andhra & Telangana - Performance
Andhra & Telangana - Performance Revenue (In INR Crs) 357 307 412 370 344 Operational Metrics 9M FY25 9M FY24 YoY Growth 303 314 279 ARPOBD (INR) 29,400+ 27,700+ 6% 9MFY24 9MFY25 FY19 FY20 FY21 FY22 FY23 FY24 Operating EBITDA1 Occupancy 55% 50% 530 bps 47 9M FY25 (In INR Crs) 33 69 Average Occupied
Slide 28: Awards, Excellence & Leadership
Awards, Excellence & Leadership
Slide 29: Awards and Rankings
Awards and Rankings Outlook 2024 Best Hospital Ranking Best Multispecialty Hospital Emerging Times All India Multispecialty Hospital Ranking 2024 Aster Medcity : All India Best Multispeciality 2 Aster Medcity: All India 1 Aster CMI Hospital: All India 4 Aster Medcity: India Best Multispecialty 3 Hos
Slide 30: Accreditation
Aster – High standards of clinical excellence Select firsts achieved by Aster Infrastructure Accreditation center of excellence in APAC – 65 year in India – Minimally in South Asia – in India – old with Parkinson’s invasive Laser Patent Foramen st Antimicrobial groundbreaking Enucleation Of the 1st
Slide 31: ESG Milestones
30 ESG Milestones 93% 85% 13 2,300,000 KWh 3,675,000 KWh 4300 E Energy Consumption sourced from renewable Energy Consumption sourced from renewable Sewage treatment plants installed across India Worth wind energy sourced Worth solar energy sourced Trees Planted energy at Aster CMI, energy at Aster R
Slide 32: Board of Directors
31 Board of Directors Shamsudheen Bin Dr. Azad Moopen Alisha Moopen T. J. Wilson Mohideen Mammu Haji Founder Chairman and Managing Deputy Managing Director Non-Executive Director Non-Executive Director Director Purana Housdurgamvijaya Chenayappillil John James Mathew Emmanuel David Gootam Deepti Geo
Slide 33: Leadership Team
32 Leadership Team Dr. Azad Moopen Founder Chairman and Managing Director T. J. Wilson Ramesh Kumar S Dr. Somashekhar S P Sunil Kumar M R Chairman-Medical Advisory Group Head - Governance & Chief Operating Officer Board & Director – Aster International Institute of Chief Financial Officer Corporate
Slide 34: Appendix
Appendix
Slide 35: Aster India Hospital and other New Business Performance – Q3 FY25
Aster India Hospital and other New Business Performance – Q3 FY25 % of Revenue Revenue Operating EBITDA(5) Hospitals and Clinics INR 1,001 Cr INR 220 Cr 93% 10% 22% Core established business YoY Revenue Growth Margins 19 hospitals(1) 13 clinics 5,128 capacity beds Labs and Pharmacies INR 78 Cr INR 3
Slide 36: Geography – wise Business – Snapshot – 9M FY25
35 Geography – wise Business – Snapshot – 9M FY25 KARNATAKA & ANDHRA & KERALA TOTAL MAHARASHTRA TELANGANA 9M FY25 9M FY24 9M FY25 9M FY24 9M FY25 9M FY24 9M FY25 9M FY24 Total Capacity Beds 2,635 2,386 1,446 1,424 1,047 1,047 5,128 4,857 Operational Beds (Census) 1,971 1,834 1,014 890 781 790 3,766
Slide 37: Geography – wise Business – Snapshot – Q3 FY25
Geography – wise Business – Snapshot – Q3 FY25 36 KARNATAKA & ANDHRA & KERALA TOTAL MAHARASHTRA TELANGANA Q3 FY25 Q3 FY24 Q3 FY25 Q3 FY24 Q3 FY25 Q3 FY24 Q3 FY25 Q3 FY24 Total Capacity Beds 2,635 2,386 1,446 1,424 1,047 1,047 5,128 4,857 Operational Beds (Census) 1,971 1,834 1,014 890 781 790 3,766
Slide 38: Thank You
Thank You Investor Relations: investors@asterdmhealthcare.com
Aster DM Healthcare — Q3 FY2025 Earnings Presentation on 6ix